Identification of inhibitors of protein kinase B using fragment-based lead discovery

J Med Chem. 2007 May 17;50(10):2293-6. doi: 10.1021/jm070091b. Epub 2007 Apr 24.

Abstract

Using fragment-based screening techniques, 5-methyl-4-phenyl-1H-pyrazole (IC50 80 microM) was identified as a novel, low molecular weight inhibitor of protein kinase B (PKB). Herein we describe the rapid elaboration of highly potent and ligand efficient analogues using a fragment growing approach. Iterative structure-based design was supported by protein-ligand structure determinations using a PKA-PKB "chimera" and a final protein-ligand structure of a lead compound in PKBbeta itself.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Binding Sites
  • Crystallography, X-Ray
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Ligands
  • Models, Molecular*
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-akt / chemistry*
  • Proto-Oncogene Proteins c-akt / genetics
  • Pyrazoles / chemical synthesis*
  • Pyrazoles / chemistry
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • 5-methyl-4-phenyl-1H-pyrazole
  • Antineoplastic Agents
  • Ligands
  • Pyrazoles
  • Recombinant Fusion Proteins
  • Adenosine Triphosphate
  • Proto-Oncogene Proteins c-akt
  • Cyclic AMP-Dependent Protein Kinases